One last bit worth noting:
"Co-Principal Investigator, Clinical Associate Professor David Packham of the Melbourne Renal Research Group said "Recent recruitment to the trial has been excellent and exceeded expectations."
Older DXB holders will remember that recruitment over a year ago was terribly slow for a long time when the trial commenced. The statement above may indicate that word of DMX200 is spreading??
Ann: Positive interim analysis of DMX-200 phase II data-DXB.AX, page-6
-
- There are more pages in this discussion • 215 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.0¢ |
Change
0.020(4.65%) |
Mkt cap ! $247.7M | |||
| Open | High | Low | Value | Volume |
| 42.5¢ | 46.3¢ | 42.5¢ | $1.449M | 3.222M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 143129 | 44.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.5¢ | 73280 | 3 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| DXB (ASX) Chart |